Clodivac

Clodivac is a vaccine designed to protect against tetanus and diphtheria. It contains tetanus and diphtheria toxoids adsorbed on aluminium hydroxide, providing immunity through subcutaneous administration.

Clodivac is primarily used for the prevention of tetanus and diphtheria. This vaccine is often administered to individuals who are at risk of exposure to these bacterial infections. It is commonly used in routine immunization schedules and for those who have not previously been vaccinated or require a booster dose.

Common effects of Clodivac may include mild redness, swelling, or pain at the injection site. Some individuals might experience mild fever, fatigue, or headache following vaccination. These effects are generally temporary and resolve on their own.

Clodivac should be administered with caution in individuals with a history of severe allergic reactions to previous doses of tetanus or diphtheria vaccines. It is important to inform healthcare providers about any allergies or medical conditions before receiving the vaccine. The vaccine should be stored and handled according to the manufacturer's guidelines to ensure its effectiveness.

Clodivac may interact with certain medications or other vaccines. It is advisable to consult with a healthcare provider before receiving Clodivac if you are taking other medications or have recently received other vaccines. Alcohol and other substances should be discussed with a healthcare provider to avoid potential interactions.